https://t.co/WJl0TLI3lA

So excited to announce our investment in Cyclana Bio - a company at the intersection of two of our favorite spaces: woman health and longevity!

Congratulations to Cyclana Bio on their £5M Pre-Seed round! We led the round alongside @eka_ventures. Cyclana Bio is building a full human tissue discovery platform to reveal how tissue and matrix biology drive chronic inflammatory disease —starting with endometriosis.

1/ Big congrats to my Co-Founder @SriniGRao, @C_Angermayer, Cosmo, and the entire teams at @ataiLife & @BeckleyPsytech on receiving FDA Breakthrough Therapy Designation (BTD) for BPL-003 (5-MeO-DMT) in treatment-resistant depression! 👏 🔗 https://t.co/CVwZlWAmtR

I don’t get the hate for @bryan_johnson. Warren Buffett is 95 and worth $100 billion. Would you trade lives with him? Almost no one would. Which means youth is worth more than $100 billion, and losing at least a billion a year. Ending aging would be the greatest achievement in

Viruses will be found to be the single main driver of all diseases.

Oh, and it’s was the AI seed round and the cancer therapy A round…

Founders! If you’re fundraising - control what you can control and better understand the seasons of fundraising

Want a sub-15-minute introduction to longevity science? This is my new go-to video: the @freethinkmedia team did an amazing job cutting two hours of me chatting down to this gorgeous brief intro to longevity. Please share far and ultra-wide!

@E11BIO is excited to unveil PRISM technology for mapping brain wiring with simple light microscopes. Today, brain mapping in humans and other mammals is bottlenecked by accurate neuron tracing. PRISM uses molecular ID codes and AI to help neurons trace themselves. We discovered

Without bio, AI utopia can't exist. AI will generate huge value, but achieving big goals — curing disease, halting climate change, extending life — requires merging AI with science. @omri_drory highlights the need for tech investors and bio founders to fulfill AI's potential ⬇️

Without Bio, the AI utopia doesn’t exist. Together, tech investors and bio founders will make the world 100x better:

Tech investors: if you’re ignoring bio, you’re missing the most defensible, IP-rich, world-changing applications of AI. Bio founders: if you don’t recognize your role in the AI revolution, you’re leaving money on the table.

Too many bio founders think: “Investors only want AI.” But AI and Bio aren’t separate stories. They’re the same story.

The real AI utopia? A world where we ▪ cure diseases ▪ end climate change ▪ extend life and healthspan Without bio (or science) none of that happens.

Sam Altman: "Increasing the rate of scientific discovery is what I'm most excited about. I believe that if you zoom all the way out, that is how the world gets sustainably better." https://t.co/cIknp0Q0wI

When @sama or Jensen Huang talk about AI’s amazing future, they’re not talking about chatbots. They’re talking about biology.

A 19-point reduction in MADRS score & NO severe adverse events - as atai’s BPL-003 just demonstrated with a 2-dose induction regimen - is truly spectacular. It proves the transformative power of psychedelics. I’m confident $ATAI will lead & ultimately own the entire sector.

Much more on this idea coming very soon in the NFX newsletter, FYI.  But in the meantime, join us!

This event is about how we take the promise of AI in bio in turn it into reality.  We cover where the opportunities and challenges are for founders.  And how investors in bio (and tech) see the space.